Chemocentryx Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Chemocentryx Contact Number

Contact Us – ChemoCentryx

5 hours ago Chemocentryx.com Show details

650.210.2900

Contact Us ChemoCentryx Headquarters 835 Industrial Rd. Suite 600 San Carlos, CA 94070 Main: +1.650.210.2900

Category: Contact SupportShow more

Contact Us ChemoCentryx, Inc.

8 hours ago Ir.chemocentryx.com Show details

650.210.2900

835 Industrial Ave. Suite 600 San Carlos, CA 94070. Phone: +1.650.210.2900. Fax: +1.650.210.2910. Email: [email protected]chemocentryx.com

Category: Contact SupportShow more

Chemocentryx, Inc. Company Profile San Carlos, CA

Just Now Dnb.com Show details

(650) 210-2900

Address. 835 Industrial Rd Ste 600. San Carlos , CA , 94070. United States. See other locations. Phone. (650) 210-2900. Company Description. Biopharmaceutical ChemoCentryx is developing drugs that target inflammatory disorders, autoimmune diseases, and cancer.

Employees: 66
Cash and Cash Equivalents: $39.18
Accounts Receivable: $0.18
Location: 835 Industrial Rd Ste 600, San Carlos, 94070

Category: Contact NumberShow more

ChemoCentryx Information ChemoCentryx Profile

Just Now Rocketreach.co Show details

Find contact info for ChemoCentryx employees Find Info Frequently Asked Questions ChemoCentryx Both in the scope of the searches, and in the number of accurate emails found, I find it surpasses others. I also like the layout, which is easy on the eye, more attractive and efficient. The bottom line is that it has been a effective tool in my

Category: Contact NumberShow more

ChemoCentryx Crunchbase Company Profile & Funding

2 hours ago Crunchbase.com Show details

Contact Email [email protected]chemocentryx.com Phone Number 16502102910 ChemoCentryx focuses on discovery, development and commercialization of orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractant receptors.

Founded: 1997

Category: Contact NumberShow more

ChemoCentryx

9 hours ago Chemocentryx.com Show details

ChemoCentryx is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer, primarily focused on orphan and rare diseases.

Category: Contact NumberShow more

ChemoCentryx Company Profile Office Locations

9 hours ago Craft.co Show details

ChemoCentryx is a biopharmaceutical company developing new medications targeted at inflammatory disorders, autoimmune diseases and cancer. Each of our drug candidates focuses on a specific chemoattractant receptor that selectively blocks its negative inflammatory or suppressive response, leaving the rest of the immune system intact.

Category: Contact NumberShow more

ChemoCentryx Email Format chemocentryx.com Emails

5 hours ago Rocketreach.co Show details

ChemoCentryx Email Format. ChemoCentryx uses 1 email formats, with first_initial last (ex. [email protected]chemocentryx.com) being used 100.0% of the time. Get Verified Emails for ChemoCentryx Employees. ChemoCentryx's Email Format.

Category: Contact NumberShow more

CCXI ChemoCentryx Inc. • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Show details

The conference ID number is 2164528. A live and archived audio webcast can be accessed through the Investors section of the Company's website at www.ChemoCentryx.com . The archived webcast will remain available on the Company's website for fourteen (14) days following the call.

Category: Contact NumberShow more

EIN 943254365 Chemocentryx, Inc., Mountain View, California

Just Now Eintaxid.com Show details

Chemocentryx, Inc. is a corporation in Mountain View, California. The employer identification number (EIN) for Chemocentryx, Inc. is 943254365. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. It is one of the corporates which submit 10-K filings with the SEC.

Category: Contact NumberShow more

ChemoCentryx Announces FDA Approval of TAVNEOS™ (avacopan

2 hours ago Ir.chemocentryx.com Show details

(877) 303-8028

ChemoCentryx will host a conference call and webcast today, October 8, 2021 at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. To participate by telephone, please dial (877) 303-8028 (Domestic) or (760) 536-5167 (International). The conference call ID number is 9576954.

Category: Contact NumberShow more

ChemoCentryx LinkedIn

5 hours ago Linkedin.com Show details

ChemoCentryx, Inc. is a biopharmaceutical company developing new medications for inflammatory and autoimmune diseases and cancer. ChemoCentryx targets …

Category: Contact NumberShow more

ChemoCentryx Employees, Board Members, Advisors & Alumni

9 hours ago Crunchbase.com Show details

ChemoCentryx develops orally administered small molecule therapeutics that target chemokine receptors and related chemo-attractants.

Category: Contact NumberShow more

ChemoCentryx Announces FDA Approval of TAVNEOS™ (avacopan

9 hours ago Finance.yahoo.com Show details

The conference call ID number is 9576954. A live and archived audio webcast can be accessed through the Investors section of the Company’s website at www.ChemoCentryx.com .

Category: Contact NumberShow more

FDA Action Alert: Takeda, ChemoCentryx, Genmab and Seagen

9 hours ago Biospace.com Show details

The U.S. Food and Drug Administration (FDA) is kicking off the month of October with a number of PDUFA dates and an advisory committee meeting. Read on for more details. Takeda Pharmaceuticals’ Maribavir for Cytomegalovirus Infection. The agency has scheduled a meeting for October 7, 2021, of the Antimicrobial Drugs Advisory Committee for Takeda Pharmaceuticals’ New …

Category: Contact NumberShow more

CHEMOCENTRYX, INC. : Shareholders Board Members Managers

6 hours ago Marketscreener.com Show details

ChemoCentryx, Inc. is a biopharmaceutical company. The Company is engaged in developing new medications targeted at inflammatory disorders, autoimmune diseases and cancer. Each of its drug candidates focuses on a specific chemoattractant receptor that selectively blocks its negative inflammatory or suppressive response, leaving the rest of the

Category: Contact NumberShow more

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages

7 hours ago Ca.finance.yahoo.com Show details

844-916-0895

Contact An Attorney Now: [email protected] 844-916-0895. ChemoCentryx, Inc. (NASDAQ: CCXI) Securities Fraud Class Action: The lawsuit focuses on ChemoCentryx's statements about its new drug application ("NDA") for its vasculitis drug candidate Avacopan.

1. Author: Newsfile Corp.

Category: Contact NumberShow more

ChemoCentryx, Inc. (NASDAQ:CCXI) Expected to Post

1 hours ago Marketbeat.com Show details

ChemoCentryx had a negative return on equity of 33.17% and a negative net margin of 568.54%. ChemoCentryx's revenue for the quarter was down 96.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.29 EPS. CCXI has been the subject of a number of research reports.

Category: Contact NumberShow more

How Is ChemoCentryx Inc. (NASDAQ: CCXI) Expected To Fare

5 hours ago Marketingsentinel.com Show details

ChemoCentryx Inc. (NASDAQ:CCXI)’s Major holders. Insiders own 23.74% of the company shares, while shares held by institutions stand at 72.45% with a share float percentage of 95.00%. Investors are also buoyed by the number of investors in a company, with ChemoCentryx Inc. having a total of 264 institutions that hold shares in the company.

Category: Contact NumberShow more

CCXI 13F Hedge Fund and Asset Management Owners

4 hours ago Whalewisdom.com Show details

835 INDUSTRIAL ROAD SAN CARLOS, CA 94070. ChemoCentryx is a biopharmaceutical company developing new medications for inflammatory and autoimmune diseases and cancer. ChemoCentryx targets the chemokine and chemoattractant systems to discover, develop and commercialize orally-administered therapies. ChemoCentryx's lead drug candidate, avacopan

Category: Contact NumberShow more

Tausif Butt Net Worth, Biography & Insider Trading History

5 hours ago Insidertrades.com Show details

(650) 210-2900

The corporate mailing address for Mr. Butt and other ChemoCentryx executives is 850 MAUDE AVENUE, MOUNTAIN VIEW CA, 94043. ChemoCentryx can also be reached via phone at (650) 210-2900 and via email at [email protected]

Category: Contact NumberShow more

ChemoCentryx (CCXI) Soars 5.4%: Is Further Upside Left in

9 hours ago Nasdaq.com Show details

ChemoCentryx CCXI shares ended the last trading session 5.4% higher at $19.60. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This

Category: Contact NumberShow more

ChemoCentryx Inc. At $18.59: Buy, Sell Or Hold

4 hours ago Marketingsentinel.com Show details

ChemoCentryx Inc. (NASDAQ:CCXI)’s traded shares stood at 2.2 million during the last session, with the company’s beta value hitting 1.41. At the close of trading, the stock’s price was $18.59, to imply a decrease of -2.16% or -$0.41 in intraday trading. The CCXI share’s 52-week high remains

Category: Contact NumberShow more

HAGENS BERMAN Encourages ChemoCentryx (CCXI) Investors

8 hours ago Finance.yahoo.com Show details

San Francisco, California--(Newsfile Corp. - June 18, 2021) - Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud

1. Author: Newsfile Corp.

Category: Contact NumberShow more

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages

7 hours ago Ca.finance.yahoo.com Show details

844-916-0895

Contact An Attorney Now: [email protected] 844-916-0895. ChemoCentryx, Inc. (NASDAQ: CCXI) Securities Fraud Class Action: The lawsuit focuses on ChemoCentryx’s statements about its new drug application (“NDA”) for its vasculitis drug candidate Avacopan.

1. Author: Hagens Berman Sobol Shapiro LLP

Category: Contact NumberShow more

ChemoCentryx Soars Most Since 2019 on Autoimmune Drug

Just Now Bnnbloomberg.ca Show details

ChemoCentryx Soars Most Since 2019 on Autoimmune Drug Approval. (Bloomberg) -- ChemoCentryx Inc. shares surged the most since November 2019 after the drug developer won U.S. approval for Tavneos as a treatment for a rare autoimmune disorder. The stock soared as much as 89% on trading volume that was more than 2,000% higher than the three-month

Category: Contact NumberShow more

ChemoCentryx (CCXI) Receives FDA Approval of TAVNEOS in

5 hours ago Streetinsider.com Show details

The conference call ID number is 9576954. A live and archived audio webcast can be accessed through the Investors section of the Company’s website at www.ChemoCentryx.com .

Category: Contact NumberShow more

ChemoCentryx, Inc. (Form: DEF 14A, Received: 04/07/2021 16

5 hours ago Content.edgar-online.com Show details

Aggregate number of securities to which transaction applies: The board of directors of ChemoCentryx, Inc. is soliciting the enclosed proxy for use at the annual meeting of stockholders to be held at the company’s headquarters, located at 835 Industrial Road, Suite 600, San Carlos, CA 94070 on May 20, 2021 at 10:00 a.m., local time

Category: Contact NumberShow more

Stock Market Daily: ChemoCentryx (CCXI) Upgradedby

7 hours ago Stockmarketdaily.co Show details

ChemoCentryx Upgradedby PiperSandler on 10/8/2021. In a note to investors, the firm issued a new rating of Overweight. The analysts previously had rating of Neutral. Shares of ChemoCentryx traded up $18.81 on Thursday, reaching $38.41. 145618099 shares of the stock traded hands, compared to its average volume of 1839278.

Category: Contact NumberShow more

Should You Buy ChemoCentryx Inc (CCXI) Stock Monday Morning?

9 hours ago Investorsobserver.com Show details

ChemoCentryx Inc has a Long-Term Technical rank of 100. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 0% of the market scoring higher. In the Biotechnology industry which is number 136 by …

Category: Contact NumberShow more

ChemoCentryx, Inc. (CCXI) Stock Price, News, Quote, Chart

Just Now Stockstelegraph.com Show details

ChemoCentryx, Inc. (CCXI) stock rallied over 5.43% intraday to trade at $19.60 a share on NASDAQ. The stock opened with a gain of 0.11% at $18.61 and touched an intraday high of $21.31, rising 14.63% against the last close of $18.59. The stock went to a low of $17.14 during the session.

Category: Contact NumberShow more

HAGENS BERMAN Encourages ChemoCentryx (CCXI) Investors

5 hours ago Ca.movies.yahoo.com Show details

844-916-0895

Contact An Attorney Now: [email protected] 844-916-0895. ChemoCentryx, Inc. (NASDAQ: CCXI) Securities Fraud Class Action: The lawsuit focuses on ChemoCentryx's statements about its new drug application ("NDA") for its vasculitis drug candidate Avacopan.

1. Author: Newsfile Corp.

Category: Contact NumberShow more

Bragar Eagel & Squire, P.C. Reminds Investors That Class

2 hours ago Sg.finance.yahoo.com Show details

NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Peloton Interactive, Inc. (NASDAQ: PTON), Repro Med Systems, Inc. d/b/a KORU Medical Systems (NASDAQ: KRMD), and ChemoCentryx, Inc. (NASDAQ: …

Category: Contact NumberShow more

Working at ChemoCentryx Glassdoor

9 hours ago Glassdoor.com Show details

Biotech & Pharmaceuticals. Revenue: $50 to $100 million (USD) Competitors: UNKNOWN. ChemoCentryx, Inc. is a biopharmaceutical company developing new medications for inflammatory and autoimmune diseases and cancer. ChemoCentryx targets the chemokine and chemoattractant systems to discover, develop and commercialize orally-administered therapies

Category: Contact NumberShow more

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages

7 hours ago Sg.finance.yahoo.com Show details

021-10-05

RESULT OF RIKSBANK REVERSED AUCTIONS KOMMUNINVEST BONDS Auction date2021-10-05Loan2311Coupon1.00 %ISIN-codeSE0010948240Maturity2023-11-13Tendered volume, SEK mln1,000 +/- 500Volume offered, SEK mln2,100 Volume bought, SEK mln1,000 Number of bids7 Number of accepted bids6 Average yield-0.047 %Lowest accepted yield-0.061 %Highest yield-0.020 …

Category: Contact NumberShow more

ChemoCentryx Shares Double After FDA Approves TAVNEOS™ for

5 hours ago Streetwisereports.com Show details

Shares of ChemoCentryx Inc. traded 101% higher after the company reported the U.S. FDA approved its orally administered TAVNEOS™ (avacopan) for use in treatment of ANCA-associated vasculitis, a systemic autoimmune disease that often results in kidney or other major organ damage and failure that can be fatal if left untreated.

Category: Contact NumberShow more

CCXI Crosses Above Average Analyst Target Nasdaq

4 hours ago Nasdaq.com Show details

2 days ago · Oct 11, 2021 8:56AM EDT. I n recent trading, shares of ChemoCentryx, Inc. (Symbol: CCXI) have crossed above the average analyst 12-month target price …

Category: Contact NumberShow more

ChemoCentryx Announces FDA Approval of TAVNEOS™ (avacopan

5 hours ago Checkorphan.org Show details

SAN CARLOS, Calif. – ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the U.S. Food and Drug Administration (FDA) has approved TAVNEOS (avacopan), an orally administered selective complement 5a receptor inhibitor, as an adjunctive treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis (also known as ANCA-associated …

Category: Contact NumberShow more

ChemoCentryx Number of Employees 20092021 CCXI

9 hours ago Macrotrends.net Show details

ChemoCentryx number of employees from 2009 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

Chemocentryx Stock Analysis 2021 CCXI Macroaxis

8 hours ago Macroaxis.com Show details

650 210-2910

ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in Mountain View, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people. For more info on Chemocentryx please contact Thomas Schall at 650 210-2910 or go to www.chemocentryx.com.

Category: Contact NumberShow more

ChemoCentryx Inc. (CCXI) (NASDAQ:CCXI) stock plunged in

9 hours ago Marketglobalist.com Show details

At last check, in the premarket trading session ChemoCentryx Inc. (CCXI) shares plunged by-62.50% to $10.31. CCXI’s stock closed the previous session at $27.49. In the past year up to date, CCXI shares plunged by -49.51%, while in the past week they slumped by -40.24%. In the past three and six months, the stock had […]

Category: Contact NumberShow more

CCXI Company Profile for CHEMOCENTRYX, INC. MSN Money

1 hours ago Msn.com Show details

ChemoCentryx, Inc. is a biopharmaceutical company. The Company is engaged in developing new medications targeted at inflammatory disorders, autoimmune diseases and cancer.

Category: Contact NumberShow more

(CCXI) Deadline Alert: Investors With Losses Over $100,000

2 hours ago Globenewswire.com Show details

If you are a ChemoCentryx shareholder and have losses greater than $100,000 and are interested in learning more about being a lead plaintiff, please contact Jim Baker ( [email protected]) at

1. Author: Johnson Fistel, LLP

Category: Contact NumberShow more

Premarket Mover: ChemoCentryx Inc (CCXI) Down 1.78%

9 hours ago Investorsobserver.com Show details

ChemoCentryx Inc has a Long-Term Technical rank of 99. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 1% of the market scoring higher. In the Biotechnology industry which is number 135 by …

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Popular Brands

Costco
Cisco
Ccu
Cae